#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Congenital ectodermal dysplasia Ichthyosis Oesophageal carcinoma Exudative retinopathy Colorectal cancer metastatic Arterial tortuosity syndrome Chronic graft versus host disease Anti-neutrophil cytoplasmic antibody positive vasculitis Breast angiosarcoma Craniocerebral injury Haemophilia A without inhibitors Astrocytoma malignant Candida infection Squamous cell carcinoma of the cervix Multifocal motor neuropathy More trials…

    Learn about Rare Diseases

    Ewing’s sarcoma – Basic Information Usher’s syndrome – Trials in Disease Adrenogenital syndrome – Basic Information Marginal zone lymphoma refractory – Life with Disease Mantle cell lymphoma stage III – Life with Disease Angiosarcoma metastatic – Trials in Disease Primary immunodeficiency syndrome – Diagnostics Urea cycle disorder – Basic Information Uterine leiomyosarcoma – Basic Information Skin angiosarcoma – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Odronextamab Setanaxib Dactinomycin Tolcapone Nicotine Resinate Avapritinib Orismilast Alnuctamab Brepocitinib Tosilate Lamotrigine Rp1 Mycophenolate Sodium Amisulpride Certolizumab Pegol Doxazosin Mesilate RO7837195 Bosentan Ibuprofen LTX-002 SODIUM Narsoplimab More therapies…

    Learn about Your Condition

    H1N1 influenza Renal transplant Fibromyalgia Pneumonia Nocturia Rhabdoid tumour Malignant neoplasm of choroid Papulopustular rosacea Critical illness Bone sarcoma Oesophageal disorder Immune system disorder Huntington's disease Pulmonary hypertension Vasospasm More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Graalum

  • A study on ketamine maintenance treatment for patients with treatment-resistant major depression disorder

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Ketamine Hydrochloride
    Norway

  • Study Comparing R-MINI-CHOP and R-MINI-CHP with Polatuzumab Vedotin for Treating Diffuse Large B-Cell Lymphoma in Patients Aged 80 and Older or Frail Patients Aged 75 and Older

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Diffuse large B-cell lymphoma refractory
    Investigated Drugs:
    • Cyclophosphamide
    • Doxorubicin Hydrochloride
    • Polatuzumab Vedotin
    Denmark Estonia Finland Italy Norway Sweden

  • A Study of Ianalumab and Eltrombopag for Patients with Primary Immune Thrombocytopenia Who Did Not Respond Well to or Relapsed After Steroid Treatment

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Immune thrombocytopenia
    Investigated Drugs:
    • Eltrombopag
    • H2-Receptor Antagonists
    • Entecavir
    Austria Belgium Czechia France Germany Hungary +5

  • Study of laroprovstat (AZD0780) tablets to lower cholesterol levels in adults with inherited high cholesterol condition (heterozygous familial hypercholesterolemia)

    Not recruiting

    3 1
    Bulgaria Czechia Denmark Finland France Germany +6

  • Study on Quality of Life in Patients Aged 16-80 with Primary Adrenal Insufficiency Using Hydrocortisone (Plenadren) and Cortisone

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Primary adrenal insufficiency
    Investigated Drugs:
    • Cortisone
    • Hydrocortisone
    Norway

  • Study on Early Treatment for Multiple Myeloma Relapse Using Carfilzomib, Bortezomib, Daratumumab, Lenalidomide, and Dexamethasone in Patients with MRD Negativity

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Betamethasone Sodium Phosphate
    • Bortezomib
    • Carfilzomib
    Lithuania Norway
Previous Page
1 … 4 5 6 7 8
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Sodium Chloride Tenecteplase Apixaban Nivolumab Acetylsalicylic Acid Asundexian Dexamethasone Pembrolizumab Cisplatin Hydrocortisone Clopidogrel Prednisone Alteplase Sodium Hydrogen Carbonate Midazolam Hydrochloride Betamethasone Valerate Vincristine Sulfate Edoxaban Depemokimab Azd5004 Fludrocortisone Acetate Empagliflozin Gentamicin Sulfate Rivaroxaban Pegfilgrastim Dapagliflozin Opevesostat Tosilate Ampicillin Sodium Quavonlimab Rilzabrutinib Show more

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

Acute myocardial infarction Alcohol use disorder Amyotrophic lateral sclerosis Aortic valve stenosis Arteriosclerosis Atrial fibrillation Bladder cancer Cancer pain Cardiac failure chronic Cardiovascular disorder Cerebrovascular accident prophylaxis Chronic kidney disease Chronic obstructive pulmonary disease Cold type haemolytic anaemia Deafness neurosensory Depression Diffuse large B-cell lymphoma refractory Glioblastoma Hormone-refractory prostate cancer Hypertension IgA nephropathy Immune thrombocytopenia Iron deficiency Ischaemic stroke Labour induction Low anterior resection syndrome Lung disorder Major depression Malignant melanoma Metabolic dysfunction-associated steatohepatitis Metastatic neoplasm Migraine Monkeypox Non-alcoholic steatohepatitis Non-small cell lung cancer Non-small cell lung cancer metastatic Pancreatic carcinoma Plasma cell myeloma Pneumonia Primary adrenal insufficiency Pulmonary embolism Renal cell carcinoma Retinal artery occlusion Sepsis Substance use disorder Thrombosis prophylaxis Transient ischaemic attack Transitional cell carcinoma metastatic Type 2 diabetes mellitus Type IIa hyperlipidaemia Warm autoimmune haemolytic anaemia

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!